9R5 Stock Price and Chart — FWB:9R5 — TradingView

Overview

About SPERMOSENS AB

Spermosens AB engages in the research and development of medical device for diagnosing male infertility. It develops a chip that employs sperm-specific receptor proteins of oocyte-origin that binds and induces a biochemical response. The response is then analyzed and determines the viability of the sperm. The company was founded by Kushagr Punyanis and Sudha Srivastavas on October 18, 2018 and is headquartered in Lund, Sweden.

Financials

Performance

Revenue to profit conversion

Debt level and coverage

Earnings

Next:—

Seasonals

Displays a symbol's price movements over previous years to identify recurring trends.

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange SPERMOSENS AB stocks are traded under the ticker 9R5.

9R5 reached its all-time high on Dec 29, 2023 with the price of 0.0800 EUR, and its all-time low was 0.0002 EUR and was reached on Nov 6, 2024. View more price dynamics on 9R5 chart.
See other stocks reaching their highest and lowest prices.

Yes, you can track SPERMOSENS AB financials in yearly and quarterly reports right on TradingView.

9R5 net income for the last quarter is ‪−213.78 K‬ EUR, while the quarter before that showed ‪−190.29 K‬ EUR of net income which accounts for −12.34% change. Track more SPERMOSENS AB financial stats to get the full picture.

No, 9R5 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

As of Mar 3, 2025, the company has 3.00 employees. See our rating of the largest employees — is SPERMOSENS AB on this list?

Like other stocks, 9R5 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SPERMOSENS AB stock right from TradingView charts — choose your broker and connect to your account.